BeOne Medicines
ONC
#629
Rank
NZ$71.32 B
Marketcap
NZ$626.97
Share price
-1.15%
Change (1 day)
9.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): NZ$10.42

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$10.70. In 2025 the company made an earnings per share (EPS) of NZ$4.88 an increase over its 2024 EPS that were of NZ-$11.17.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$10.42113.31%
2025NZ$4.88-143.75%
2024NZ-$11.17
2022NZ-$34.8928.21%
2021NZ-$27.22-19.96%
2020NZ-$34.0020.81%
2019NZ-$28.1531.52%
2018NZ-$21.40417.57%
2017NZ-$4.13-37.16%
2016NZ-$6.58158.95%
2015NZ-$2.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.16-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.70-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA